Long-term changes of amyloid β peptide 42 and nerve growth factor expression in the hippocampus of experimental diabetic mice

doi:10.3969/j.issn.1006-7795.2013.06.014

Abstract

Abstract:

Objective To observe the long-term changes in expression of amyloid β peptide(Aβ) 42 and nerve growth factor(NGF) in the hippocampus of experimental diabetic mice and to explore the mechanism of diabetic encephalopathy. Methods Sixty-four male mice were divided into a control(C) group(n=32) and a diabetic mellitus(DM) group(n=32) randomly. Streptozocin was freshly prepared and injected at 200 mg/kg, i.p. into mice which had been fasted for 12 h. Three days later, blood glucose in a tail-vein sample was determined; a value ≥15 mmol/L was accepted as a successful induction of a diabetic model. The expression changes of Aβ42 and NGF in the hippocampal CA1 region of C group and DM group mice were studied by immunohistochemical staining at the 4 time-points of 1 week, 4 weeks, 8 weeks and 12 weeks after DM models were established. Results 1. There were slightly stained Aβ42-positive cells in hippocampal CA1 region of C group mice, while more darkly stained Aβ42-positive cells in hippocampal CA1 region were found in DM group mice at the 4 time-points. The numbers of Aβ42-positive cells in hippocampal CA1 region of DM group mice at 1 week(14.10±3.60) increased a little compared with that of C group mice(13.20±3.08) with no significant difference(P>0.05), while the numbers of Aβ42-positive cells in the hippocampal CA1 region of DM group mice at 4 weeks, 8 weeks and 12 weeks(16.10±3.67, 16.20±2.86, 17.50±3.10) increased significantly(P<0.01) compared with those of C group mice(11.70±2.54, 12.00±2.67, 10.80±2.92). 2. That there were some darkly stained NGF-positive cells in hippocampal CA1 region of C group mice. DM group mice at the 4 time-points also had some NGF-positive cells in hippocampal CA1 region although the staining was a little pale. There were no significant differences between the numbers of NGF-positive cells in the hippocampal CA1 region of DM group mice at the 4 time-pointsand those of group C mice(P>0.05). Conclusion The expression of Aβ42 in the hippocampus of DM mice increased significantly compared with that of normal control mice at the middle stage of DM(4 weeks) and sustained till the end of this study(DM 12 weeks). The expression of NGF in the hippocampus of DM mice did not change significantly in this study. Aβ42 might be involved in the degenerative process of hippocampal neurons in DM mice and play an important role in the pathogenesis of diabetic encephalopathy.

Key words: diabetes mellitus, encephalophathy, hippocampus, amyloid &beta, peptide 42, nerve growth factor

CLC Number:

R587.1

ZHAO Yongmei, YAN Ying, ZHAO Zhiwei. Long-term changes of amyloid β peptide 42 and nerve growth factor expression in the hippocampus of experimental diabetic mice[J]. Journal of Capital Medical University, 2013, 34(6): 851-855.

0
/ / Recommend

Add to citation manager EndNote|Reference Manager|ProCite|BibTeX|RefWorks

URL: https://journal03.magtech.org.cn/Jweb_sdykdxxb/EN/10.3969/j.issn.1006-7795.2013.06.014

https://journal03.magtech.org.cn/Jweb_sdykdxxb/EN/Y2013/V34/I6/851

References

[1] Mijnhout G S, Scheltens P, Diamant M, et al. Diabetic encephalopathy: a concept in need of a definition[J]. Diabetologia, 2006, 49(6):1447-1448.
[2] Kamboj S S, Chopra K, Sandhir R. Neuroprotective effect of N-acetylcysteine in the development of diabetic encephalopathy in streptozotocin-induced diabetes[J]. Metab Brain Dis, 2008, 23(4):427-443.
[3] Findeis M A. The role of amyloid beta peptide 42 in Alzheimer's disease[J]. Pharmacol Ther, 2007, 116(2):266-286.
[4] Lim Y A, Grimm A, Giese M, et al. Inhibition of the mitochondrial enzyme ABAD restores the amyloid-β-mediated deregulation of estradiol[J]. PLoS One, 2011, 6(12):e28887.
[5] Yao J, Du H, Yan S, et al. Inhibition of amyloid-beta(Abeta) peptide-binding alcohol dehydrogenase-Abeta interaction reduces Abeta accumulation and improves mitochondrial function in a mouse model of Alzheimer's disease[J]. J Neurosci, 2011, 31(6):2313-2320.
[6] 闫颖, 李森, 赵志炜, 等.β淀粉样肽结合乙醇脱氢酶及胆碱乙酰转移酶在糖尿病小鼠海马内表达的时程变化[J].首都医科大学学报, 2013, 34(1):53-57.
[7] Sposato V, Manni L, Chaldakov G N. Streptozotocin-induced diabetes is associated with changes in NGF levels in pancreas and brain[J]. Arch Ital Biol, 2007, 145(2):87-97.
[8] Zhao Y M, Pei J J, Ji Z J, et al. Effect of amyloid precursor protein 17mer peptide on microtubule structure and tau protein hyperphosphorylation in hippocampal neurons of experimental diabetic mice[J]. Neuroreport, 2003, 14(1):61-66.
[9] Shuli S, Yongmei Z, Zhiwei Z, et al. beta-Amyloid and its binding protein in the hippocampus of diabetic mice: effect of APP17 peptide[J]. Neuroreport, 2001, 12(15):3317-3319.
[10] Lustbader J W, Cirilli M, Lin C, et al. ABAD directly links Abeta to mitochondrial toxicity in Alzheimer's disease[J]. Science, 2004, 304(5669):448-452.
[11] Yao J, Irwin R, Chen S, et al. Ovarian hormone loss induces bioenergetic deficits and mitochondrial β-amyloid[J]. Neurobiol Aging, 2012, 33(8):1507-1521.
[12] 闫颖, 赵咏梅, 赵志炜, 等.内质网应激通路相关分子GRP78及CHOP在糖尿病脑病小鼠海马表达的变化[J].首都医科大学学报, 2011, 32(1):90-94.
[13] Muresan V, Muresan Z. A persistent stress response to impeded axonal transport leads to accumulation of amyloid-β in the endoplasmic reticulum, and is a probable cause of sporadic Alzheimer's disease[J]. Neurodegener Dis, 2012, 10(1-4):60-63.
[14] Kim H J, Cho H K, Kwon Y H. Synergistic induction of ER stress by homocysteine and beta-amyloid in SH-SY5Y cells[J]. J Nutr Biochem, 2008, 19(11):754-761.
[15] Chae C H, Kim H T. Forced, moderate-intensity treadmill exercise suppresses apoptosis by increasing the level of NGF and stimulating phosphatidylinositol 3-kinase signaling in the hippocampus of induced aging rats[J]. Neurochem Int, 2009, 55(4):208-213.
[16] Ji C, Song C, Zuo P. The mechanism of memory impairment induced by Aβ chronic administration involves imbalance between cytokines and neurotrophins in the rat hippocampus[J]. Curr Alzheimer Res, 2011, 8(4):410-420.